Taro Pharmaceutical Industries Ltd is a pharmaceutical company that develops, manufactures and markets generic, branded prescription and over-the-counter (OTC) pharmaceutical products. Taro’s primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly for the dermatological, topical, cardiovascular, neuropsychiatric, analgesics, gastro, CNS and anti-inflammatory therapeutic categories. The company was established in 1950, and in 2010 Sun Pharmaceutical Industries Ltd acquired the majority stake of the company.